A method for preparing graphene oxide-based porous hydrogels and their applications

By preparing graphene oxide-based porous hydrogel, the problem of insufficient adsorption capacity and difficulty in separation of antibiotics and heavy metal ions in medical wastewater is solved, and the efficient waste liquid treatment effect is achieved.

CN118812799BActive Publication Date: 2024-11-26SOUTHWEST PETROLEUM UNIV
0 Cites 0 Cited by

Patent Information

Application Number
CN202411290130.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-14
Publication Date
2024-11-26
Estimated Expiration
2044-09-14

AI Technical Summary

Technical Problem

The existing solid adsorbents have insufficient adsorption capacity of antibiotics and heavy metal ions in medical wastewater and are not easy to be completely separated from the aqueous solution, resulting in low treatment efficiency and environmental pollution.

Method used

The preparation method of graphene oxide-based porous hydrogel is prepared by phosphorus-doped graphene oxide PGO, chemical modification reaction and free radical polymerization to form water-insoluble and under heavy metal environment Stable adsorbent material.

Benefits of technology

The removal rate of antibiotics and heavy metal ions in medical wastewater has been improved, the problems of poor adsorption capacity and difficulty in separation have been solved, and efficient waste liquid treatment has been achieved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118812799B_ABST
    Figure CN118812799B_ABST
Patent Text Reader

Abstract

The present invention provides a preparation method and application of a graphene oxide-based porous hydrogel, which belongs to the technical field of medical wastewater treatment, including: preparing phosphorus-doped graphene oxide PGO; according to phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, obtaining triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA through chemical modification reaction; synthesizing acryloyl chloride-modified β-cyclodextrin monomer A-β-CD; triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, acryloyl chloride-modified β-cyclodextrin monomer A-β-CD and cross-linking promoter TMEDA, emulsifier SDS, initiator AIBN are mixed, and graphene oxide-based porous hydrogel is prepared by free radical polymerization. The graphene oxide-based hydrogel material prepared by the present invention is insoluble in water, has strong stability in a heavy metal environment, and has a high adsorption rate for quinolone antibiotics.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical wastewater treatment, and in particular to a method for preparing a graphene oxide-based porous hydrogel and an application thereof. Background Art

[0002] With the rapid development of modern medical care, scholars have found that most microorganisms have low resistance to antibiotics. The use of antibiotics can effectively destroy the physiological tissues of microorganisms and achieve the purpose of treatment. Therefore, the use and production of antibiotics have also reached a peak. Most antibiotics are biological products, that is, they are made through biological fermentation. There are hundreds of antibiotic production companies in my country, but there are still a lot of technical difficulties in the production process, resulting in low raw material utilization, low extraction purity, and high residual antibiotic content in wastewater. And with the large-scale use of antibiotics and the random discharge of production waste liquid, microorganisms have shown obvious drug resistance. Moreover, the discarded antibiotic liquid after use contains a large amount of harmful substances. It is a kind of organic solution with complex components, difficult to degrade, and high toxicity. If it is directly discharged into the environment, it is very easy to pollute the water body, leading to the deterioration of the ecological environment, and it will also pose a major threat to human health.

[0003] At present, traditional physical method is one of the important methods for treating medical wastewater, among which adsorption method is the most commonly used and mature method. Solid adsorbents are usually used to adsorb antibiotics in medical waste liquid to the surface to achieve the removal effect. It can treat a large amount of medical wastewater, but the operation cost is high, time-consuming, and can only treat high-concentration antibiotic waste liquid. Therefore, how to treat the waste economically, efficiently and stably has become the focus of attention today.

[0004] Among the commonly used solid adsorbents, activated carbon has a large specific surface area, which makes it have good adsorption for antibiotics. However, in actual use, the adsorption capacity of activated carbon for antibiotics is limited, and it is easy to reach a saturated state. In addition, the service life of activated carbon is short, and the efficiency gradually decreases during the catalytic adsorption of antibiotics, so that the expected removal effect cannot be achieved. Its allotropic graphene material also has excellent adsorption capacity. Its unique honeycomb double-layer two-dimensional structure makes it have a larger specific surface area than activated carbon, which can provide more active sites and relatively prolong the time to reach a saturated state. Secondly, because the honeycomb structure of graphene-based materials is more stable than activated carbon and is not easily oxidized, its service life is relatively long, which makes the cost of the removal process relatively low, but the adsorption effect is also related to the concentration of antibiotics in the waste liquid, and the adsorption effect for low-concentration waste liquid is not ideal. Therefore, some scholars have proposed to dope oxidants into graphene-based materials. First, low-concentration antibiotics are oxidized by oxidants, and then adsorbed into graphene-based materials, thereby improving the removal capacity of antibiotics. However, there are still a large number of heavy metal ions in medical waste liquid that affect the oxidative adsorption of antibiotics, and the single graphene material is not easy to separate from the aqueous solution. Summary of the invention

[0005] In order to overcome the shortcomings of the prior art, the purpose of the present invention is to provide a method for preparing a graphene oxide-based porous hydrogel and its application. The prepared graphene oxide-based hydrogel material is insoluble in water, has strong stability in a heavy metal environment, and has a high adsorption rate for quinolone antibiotics, thereby solving the problems of poor adsorption capacity of solid adsorbents for discarded antibiotics and heavy metal ions in medical wastewater, and difficulty in complete separation from aqueous solutions.

[0006] To achieve the above object, the present invention provides the following solutions:

[0007] A method for preparing a graphene oxide-based porous hydrogel comprises the following steps:

[0008] Preparation of phosphorus-doped graphene oxide PGO;

[0009] According to the phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, and chemically modifying the mixture to obtain triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA;

[0010] Synthesis of acryloyl chloride modified β-cyclodextrin monomer A-β-CD;

[0011] The triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD, a cross-linking promoter TMEDA, an emulsifier SDS, and an initiator AIBN are mixed to prepare a graphene oxide-based porous hydrogel through a free radical polymerization method.

[0012] Preferably, the process for preparing phosphorus-doped graphene oxide PGO is: adding 0.5 g of graphene oxide GO and 100 ml of pure water into a 250 ml round-bottom flask, and mixing them evenly by ultrasonication; then adding 8 g of H3PO2 and reacting them in an oil bath at 80° C. for 5 h; then centrifuging, washing, and drying to obtain the phosphorus-doped graphene oxide PGO.

[0013] Preferably, according to the phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, and obtaining triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA through chemical modification reaction, the preparation process is: 0.3g of the phosphorus-doped graphene oxide PGO and 15ml of PBS buffer are mixed and ultrasonically stirred evenly, and 0.6g of TETA is added during the stirring process and ultrasonically stirred evenly; then reacting for 30min under ice bath conditions, adding 0.09g of EDC and 0.03g of NHS to react for 1h; then placing the mixed solution at room temperature to react for 24h; finally washing with pure water and vacuum drying at 60°C to obtain the triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA.

[0014] Preferably, the process for synthesizing the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD is as follows: first, anhydrous Na2SO4 is added to 50 ml DMF to obtain dry DMF; then 20 ml of dry DMF, 1.5 g of cyclodextrin β-CD and 7 ml of triethylamine are added to a 50 ml round-bottom flask in sequence; then an ice bath is performed and N2 is introduced, while 1.25 ml of acryloyl chloride is added dropwise, and the mixture is reacted in an oil bath at 30° C. for 30 min; then, the mixture is filtered through a circulating water vacuum pump to obtain a filtrate, acetone is added to the filtrate, the solid is filtered again to obtain the solid, and the solid is washed with acetone, and finally dried to obtain the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD.

[0015] Preferably, the triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD, the crosslinking promoter TMEDA, the emulsifier SDS, and the initiator AIBN are mixed to prepare the graphene oxide-based porous hydrogel by free radical polymerization. First, 0.05 g of triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA is added to 2.5 ml of pure water and ultrasonically mixed uniformly, and then 0.015 g of crosslinking agent MBA, 2.5 μL of crosslinking promoter TMEDA, 0.1 g of emulsifier SDS and 0.0052 g of initiator AIBN are weighed; then, by a one-step free radical polymerization method, in 2.5 ml Free radical polymerization of 0.3 g monomer AMPS and 0.1 g β-cyclodextrin monomer A-β-CD modified with acryloyl chloride was initiated in triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA solution; then the reaction was continued at 80 °C for 2 h, and the mixture was washed with pure water and dried to obtain graphene oxide-based porous hydrogel PGOT@GEL.

[0016] The present invention also provides an application of the graphene oxide-based porous hydrogel prepared by the above-mentioned preparation method in the treatment of medical wastewater.

[0017] According to the specific embodiments provided by the present invention, the present invention discloses the following technical effects:

[0018] (1) The present invention utilizes the characteristics of hydrogel itself, which is small in size but can swell rapidly in water and maintain a large volume of water without being soluble. The two are connected through a cross-linking agent to form a graphene oxide-based porous hydrogel system. The porous characteristics of the hydrogel can also effectively increase the pathways for antibiotics, heavy metal ions, etc. to enter the graphene-based material, thereby improving the removal rate of antibiotics and heavy metal ions in medical waste liquid.

[0019] (2) The graphene oxide-based hydrogel material prepared by the present invention is insoluble in water, has strong stability in a heavy metal environment, and has a high adsorption rate for quinolone antibiotics, thereby solving the problems of poor adsorption capacity of solid adsorbents for discarded antibiotics and heavy metal ions in medical wastewater, and difficulty in complete separation from aqueous solutions. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0021] Figure 1 This is a flow chart of a method for preparing a graphene oxide-based porous hydrogel according to the present invention;

[0022] Figure 2 FT-IR spectra of GO, PGO, TETA-PGO and PGOT@GEL provided in Example 1 of the present invention;

[0023] Figure 3 Thermogravimetric curves of GO, PGO, TETA-PGO and PGOT@GEL provided in Example 1 of the present invention;

[0024] Figure 4 The standard curve diagram of CIP and GAT provided in the second embodiment of the present invention; wherein, Figure 4 (a) is the standard curve of CIP. Figure 4 (b) is the standard curve of GAT;

[0025] Figure 5 Removal of CIP and Cu in the binary system provided in Example 2 of the present invention 2+ The adsorption capacity ratio bar graph of Figure 5 (a) is a bar graph showing the adsorption capacity ratio for removing CIP. Figure 5 (b) is to remove Cu 2+ The adsorption capacity ratio bar graph. DETAILED DESCRIPTION

[0026] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0027] In order to make the purpose, features and advantages of the present invention more obvious and easy to understand, the present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.

[0028] Embodiment 1

[0029] like Figure 1 As shown, the present invention provides a method for preparing a graphene oxide-based porous hydrogel, comprising the following steps:

[0030] Step 100: preparing phosphorus-doped graphene oxide PGO;

[0031] Step 200: According to the phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, and obtaining triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA through chemical modification reaction;

[0032] Step 300: synthesizing acryloyl chloride-modified β-cyclodextrin monomer A-β-CD;

[0033] Step 400: The triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD, the cross-linking promoter TMEDA, the emulsifier SDS, and the initiator AIBN are mixed to prepare a graphene oxide-based porous hydrogel by free radical polymerization.

[0034] In step 100, the process of preparing phosphorus-doped graphene oxide PGO is as follows: 0.5 g of graphene oxide GO and 100 ml of pure water are added to a 250 ml round-bottom flask and mixed evenly by ultrasonication; then 8 g of H3PO2 is added and reacted in an oil bath at 80° C. for 5 hours; then the phosphorus-doped graphene oxide PGO is obtained by centrifugation, washing, and drying.

[0035] In step 200, according to the phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, and obtaining triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA through chemical modification reaction, the preparation process is as follows: 0.3g of the phosphorus-doped graphene oxide PGO and 15ml of PBS buffer are mixed and ultrasonically stirred evenly, and 0.6g of TETA is added during the stirring process and ultrasonically stirred evenly; then, the mixture is reacted for 30min under ice bath conditions, 0.09g of EDC and 0.03g of NHS are added and reacted for 1h; then, the mixed solution is placed at room temperature and reacted for 24h; finally, it is washed with pure water and vacuum dried at 60°C to obtain the triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA.

[0036] In step 300, the process of synthesizing the β-cyclodextrin monomer A-β-CD modified with acryloyl chloride is as follows: first, anhydrous Na2SO4 is added to 50 ml of DMF to obtain dry DMF; then 20 ml of dry DMF, 1.5 g of cyclodextrin β-CD and 7 ml of triethylamine are added to a 50 ml round-bottom flask in sequence; then an ice bath is performed and N2 is introduced, while 1.25 ml of acryloyl chloride is added dropwise, and the mixture is reacted in an oil bath at 30° C. for 30 minutes; then, the mixture is filtered through a circulating water vacuum pump to obtain a filtrate, acetone is added to the filtrate, the solid is filtered again to obtain the solid, and the solid is washed with acetone, and finally, the solid is dried to obtain the β-cyclodextrin monomer A-β-CD modified with acryloyl chloride.

[0037] In step 400, the triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD, the crosslinking promoter TMEDA, the emulsifier SDS, and the initiator AIBN are mixed to prepare the graphene oxide-based porous hydrogel by free radical polymerization. First, 0.05 g Triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA was added to 2.5 ml pure water and ultrasonically mixed evenly, then 0.015 g crosslinker MBA, 2.5 μL crosslinking promoter TMEDA, 0.1 g emulsifier SDS and 0.0052 g initiator AIBN were weighed; then, through a one-step free radical polymerization method, 0.3 g monomer AMPS and 0.1 g acryloyl chloride-modified β-cyclodextrin monomer A-β-CD were initiated in 2.5 ml triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA solution. Then, the reaction was continued at 80 ° C for 2 h, and the mixture was washed with pure water and dried to obtain the graphene oxide-based porous hydrogel PGOT@GEL.

[0038] In this example, the characterization of graphene oxide-based porous hydrogel structures is described, referring to Figure 2 ,from Figure 2 It can be seen that at 3415 cm -1 、1724 cm -1 、1628 cm -1 , 1400 cm -1 and 1087 cm -1 The absorption peaks at 1317 cm-1 correspond to the stretching vibration of -OH, the stretching vibration of C=O, the skeleton vibration of C=C bond, the symmetric stretching vibration of C-OH and the stretching vibration of epoxy group COC, indicating that the above-mentioned graphene oxide GO was successfully prepared; and in the spectrum shown in PGO, not only the characteristic peak corresponding to graphene oxide GO appeared, but also the peak at 1317 cm-1 -1 and 762 cm -1 New absorption peaks appeared at 1567 cm-1, corresponding to the stretching vibrations of -P=O and -PC bonds, respectively. It can be seen that the above preparation method successfully prepared phosphorus-doped graphene oxide PGO. From the TETA-PGO spectrum, it can be seen that at 1567 cm-1, -1 A new absorption peak appeared at 1304 cm-1, which corresponds to the stretching vibration of NH, indicating that TETA successfully modified PGO in the above preparation method. -1 、1203 cm -1 and 1045 cm -1 The peaks at 1637 cm-1 belong to the symmetric stretching vibration of S=O, the symmetric stretching vibration of the sulfonic acid group O=S=O, and the stretching vibration of -SO3H. -1The C=C stretching vibration peak of A-β-CD synthesized by acryloyl substitution reaction appeared at the above results, indicating that AMPS and A-β-CD were successfully copolymerized, indicating the feasibility of preparing PGOT@GEL by free radical polymerization.

[0039] In addition, refer to Figure 3 , GO, PGO, TETA-PGO and PGOT@GEL all have a certain weight loss before 100℃, which is due to the evaporation of residual water in the sample. For sample GO, the weight loss is about 48.76% between 100-600℃, of which GO loses about 34.77% between 100-300℃, which is due to the decomposition of unstable oxygen-containing functional groups; between 300-600℃, GO loses about 13.99% of its weight, which is due to the decomposition of stable oxygen-containing functional groups. In the PGO weight loss curve, the weight loss at 100-600℃ is about 28.48%, which is because H3PO2 interacts with -COOH, -C=O and other groups on the surface of GO, and the thermal stability is increased compared to GO. For TETA-PGO, the weight loss is about 32.67% between 100-600℃, which is because the thermal stability decreases after TETA is grafted. For PGOT@GEL, the weight loss is about 72.09% between 100-600°C, and the main weight loss stage occurs at 250-500°C, which is due to the thermal cracking of the polymer chain segment. Therefore, according to the above content, the graphene oxide-based porous hydrogel PGOT@GEL can be successfully prepared by the preparation method provided in this embodiment.

[0040] Embodiment 2

[0041] In this example, the co-adsorption performance of the graphene oxide-based porous hydrogel PGOT@GEL prepared in Example 1 is described in detail. The specific experimental process is: weigh 10 mg of ciprofloxacin CIP and trovafloxacin GAT solids and dissolve them in pure water, then transfer them to a 100 mL volumetric flask to make up to volume to obtain 100 mg / L CIP solution and GAT solution. Take 1 mL, 2 mL, 3 mL, 4 mL, and 5 mL of 100 mg / L CIP solution and GAT solution in 50 mL colorimetric tubes, respectively, dilute with water to the mark, and shake well. Then use an ultraviolet spectrophotometer to measure the absorbance of the solution in the colorimetric tube at wavelengths of 272 nm and 286 nm, respectively, and obtain Figure 4 The standard curve of CIP shown in (a) and Figure 4 The standard curve of GAT shown in (b) shows that the concentrations of CIP and GAT have a linear relationship with the corresponding absorbance.

[0042] In addition, in the binary system, CIP and Cu2+ In the case of coexistence, the interaction between the two. 2+ Impact on CIP: The initial concentration of CIP was set at 0-100 mg / L, Cu 2+ The initial concentration of CIP is 0-30 mg / L, pH=6. 2+ Impact: Setting Cu 2+ The initial concentration of 0-100 mg / L, the initial concentration of CIP was 0-100 mg / L, and pH = 5. The solid-liquid ratio was 0.5 g / L.

[0043] The adsorption amount of CIP q is calculated according to the following formula (1): e (mg / g), using adsorption capacity ratio (R q )Formula (2) verifies the relationship between CIP and Cu 2+ interaction.

[0044] (1);

[0045] Where, C0——concentration of antibiotic solution before adsorption, (mg / L);

[0046] C e ——adsorption equilibrium concentration of antibiotic solution, (mg / L);

[0047] q e ——equilibrium adsorption capacity, (mg / g);

[0048] V ——Volume of antibiotic solution, (mL);

[0049] m ——Amount of adsorbent used, (mg).

[0050] (2);

[0051] In the formula, q b,i ——The adsorption amount of CIP in the binary system;

[0052] q s,i ——The adsorption amount of CIP in a single system.

[0053] Through experiments to explore the 2+ and Cu 2+ -CIP and Cu in CIP binary system 2+ The mutual influence between q ) to analyze the interaction between them. It can be seen that when R q<1, it indicates that the coexisting pollutants in the binary system play an antagonistic role; when R q =1, indicating that the coexisting pollutants in the binary system have no effect; when R q When >1, it indicates that the coexisting pollutants in the binary system play a synergistic role.

[0054] Reference Figure 5 As shown in (a), when Cu 2+ When the concentration increases from 0 mg / L to 30 mg / L, it plays a synergistic role in the adsorption of CIP (R q >1), this is due to Cu 2+ Forming positively charged CIP-Cu 2+ The complexes promote the adsorption of CIP. In addition, the initial concentration of CIP also affects its adsorption with Cu. 2+ As the CIP concentration increased from 0 mg / L to 100 mg / L, the synergistic effect of CIP and Cu 2+ The synergistic effect between CIP and Cu 2+ The synergistic effect between them increases accordingly (for example, when the initial concentration of CIP increases to 80 mg / L, R q =1.14); However, when the CIP concentration continues to increase, the 2+ The synergistic effect between them will be weakened to a certain extent, and more CIP-Cu 2+ complexes (e.g., when the initial concentration of CIP increased to 100 mg / L, R q =1.09).

[0055] Reference Figure 5 As shown in (b), when the CIP concentration increases from 0 mg / L to 100 mg / L, the 2+ The adsorption of q >1), this is because there are many ligand functional groups in CIP, which provide additional oxygen active sites (N, F, O and -OH active sites) for Cu 2+ The adsorption of Cu 2+ Form CIP-Cu with CIP 2+ The complex resulted in PGOT@GEL to Cu 2+ However, when the CIP concentration increased to 100 mg / L, the adsorption capacity of Cu 2+ The promotion effect of Cu 2+ The weight and size are smaller, and it can be put into PGOT@GEL faster than CIP.2+ The initial concentration of Cu will also have a certain impact on the synergistic effect between the two. 2+ When the concentration increases from 0 mg / L to 100 mg / L, the synergistic effect between the two shows a trend of first increasing and then decreasing. This is because as the concentration of Cu 2+ The initial concentration of Cu 2+ The concentration gradient driving force gradually increases (for example, when Cu 2+ When the initial concentration increased to 60 mg / L, R q =1.20), but Cu 2+ When the concentration continued to increase, the adsorption sites of PGOT@GEL were limited, resulting in the adsorption of CIP and Cu 2+ There is a certain amount of competitive adsorption between them (for example, when Cu 2+ When the initial concentration of R increases to 100 mg / L, q =1.10).

[0056] Therefore, according to the above content, it is proved that the graphene oxide-based porous hydrogel PGOT@GEL prepared by the preparation method provided by the present invention can be applied to medical wastewater treatment to remove quinolone antibiotics and heavy metals in water.

[0057] The beneficial effects of the present invention are as follows:

[0058] (1) The present invention utilizes the characteristics of hydrogel itself, which is small in size but can swell rapidly in water and maintain a large volume of water without being soluble. The two are connected through a cross-linking agent to form a graphene oxide-based porous hydrogel system. The porous characteristics of the hydrogel can also effectively increase the pathways for antibiotics, heavy metal ions, etc. to enter the graphene-based material, thereby improving the removal rate of antibiotics and heavy metal ions in medical waste liquid.

[0059] (2) The graphene oxide-based hydrogel material prepared by the present invention is insoluble in water, has strong stability in a heavy metal environment, and has a high adsorption rate for quinolone antibiotics, thereby solving the problems of poor adsorption capacity of solid adsorbents for discarded antibiotics and heavy metal ions in medical wastewater, and difficulty in complete separation from aqueous solutions.

[0060] The various embodiments in this specification are described in a progressive manner, and each embodiment focuses on the differences from other embodiments. The same or similar parts between the various embodiments can be referenced to each other.

[0061] The principles and implementation methods of the present invention are described in this article using specific examples. The description of the above embodiments is only used to help understand the method and core idea of ​​the present invention. At the same time, for those skilled in the art, according to the idea of ​​the present invention, there will be changes in the specific implementation methods and application scope. In summary, the content of this specification should not be understood as limiting the present invention.

Claims

1. A method for preparing a graphene oxide-based porous hydrogel, characterized in that: The following steps are involved: Preparation of phosphorus-doped graphene oxide PGO; According to the phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, and chemically modifying the mixture to obtain triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA; Synthesis of acryloyl chloride modified β-cyclodextrin monomer A-β-CD; The triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD, a cross-linking promoter TMEDA, an emulsifier SDS, and an initiator AIBN are mixed to prepare a graphene oxide-based porous hydrogel by a free radical polymerization method; The triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA, the acryloyl chloride-modified β-cyclodextrin monomer A-β-CD, the crosslinking promoter TMEDA, the emulsifier SDS, and the initiator AIBN are mixed to prepare the graphene oxide-based porous hydrogel by free radical polymerization. The process is as follows: first, 0.05 g of triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA is added to 2.5 ml of pure water and ultrasonically mixed evenly, then 0.015 g of crosslinking agent MBA, 2.5 μL of crosslinking promoter TMEDA, 0.1 g of emulsifier SDS, and 0.0052 g of initiator AIBN are weighed; then, by a one-step free radical polymerization method, in 2.5 ml Free radical polymerization of 0.3 g monomer AMPS and 0.1 g β-cyclodextrin monomer A-β-CD modified with acryloyl chloride was initiated in triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA solution; then the reaction was continued at 80 °C for 2 h, and the mixture was washed with pure water and dried to obtain graphene oxide-based porous hydrogel PGOT@GEL.

2. The method for preparing a graphene oxide-based porous hydrogel according to claim 1, characterized in that: The process for preparing phosphorus-doped graphene oxide PGO is as follows: 0.5 g of graphene oxide GO and 100 ml of pure water are added into a 250 ml round-bottom flask, and ultrasonically mixed; then 8 g of H3PO2 is added and reacted in an oil bath at 80° C. for 5 h; then the phosphorus-doped graphene oxide PGO is obtained by centrifugation, washing, and drying.

3. The method for preparing a graphene oxide-based porous hydrogel according to claim 2, characterized in that: According to the phosphorus-doped graphene oxide PGO, by mixing PBS buffer, adding EDC and NHS, and obtaining triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA through chemical modification reaction, the preparation process is as follows: 0.3g of the phosphorus-doped graphene oxide PGO and 15ml of PBS buffer are mixed and ultrasonically stirred evenly, and 0.6g of TETA is added during the stirring process and ultrasonically stirred evenly; then, the reaction is carried out under ice bath conditions for 30min, 0.09g of EDC and 0.03g of NHS are added and reacted for 1h; then, the mixed solution is placed at room temperature to react for 24h; finally, it is washed with pure water and vacuum dried at 60°C to obtain the triethylenetetramine-modified phosphorus-doped graphene oxide PGO-TETA.

4. The method for preparing a graphene oxide-based porous hydrogel according to claim 1, characterized in that: The process of synthesizing the acryloyl chloride modified β-cyclodextrin monomer A-β-CD is as follows: first, anhydrous Na2SO4 is added to 50 ml of DMF to obtain dry DMF; then, 20 ml of dry DMF, 1.5 g of cyclodextrin β-CD and 7 ml of triethylamine are added to a 50 ml round-bottom flask in sequence; then, an ice bath is performed and N2 is introduced, and 1.25 ml of acryloyl chloride is added dropwise, and the mixture is reacted in an oil bath at 30° C. for 30 minutes; then, the mixture is filtered through a circulating water vacuum pump to obtain a filtrate, acetone is added to the filtrate, and the solid is filtered again to obtain the solid, which is washed with acetone, and finally dried to obtain the acryloyl chloride modified β-cyclodextrin monomer A-β-CD.

5. Application of the graphene oxide-based porous hydrogel prepared by the method for preparing the graphene oxide-based porous hydrogel according to any one of claims 1 to 4 in the treatment of medical wastewater.